Literature DB >> 21508563

Intralesional immunotherapy for the management of warts.

Laxmisha Chandrashekar.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 21508563     DOI: 10.4103/0378-6323.79694

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  13 in total

1.  Intralesional Immunotherapy with Measles Mumps Rubella Vaccine for the Treatment of Anogenital Warts: An Open-label Study.

Authors:  Shilpi Sharma; Saurabh Agarwal
Journal:  J Clin Aesthet Dermatol       Date:  2020-08-01

2.  A Comparative Study of Intralesional Vitamin D3, Measles Mumps Rubella Vaccine, and Tuberculin Purified Protein Derivative in the Treatment of Recalcitrant Warts: An Approach to Solve a Therapeutic Conundrum.

Authors:  Srishti Jain; Yogesh S Marfatia
Journal:  J Clin Aesthet Dermatol       Date:  2021-11

3.  A Study to Evaluate the Role of Intradermal and Intralesional Measles, Mumps, Rubella (MMR) Vaccine in Treatment of Common Warts.

Authors:  Pragya Gupta; Geeta Ram Tegta; G K Verma; Abhishek Gupta; Mudita Gupta; Shikha Sharma
Journal:  Indian Dermatol Online J       Date:  2020-07-13

Review 4.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

5.  Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine.

Authors:  Shilpa Garg; Sukriti Baveja
Journal:  J Cutan Aesthet Surg       Date:  2014 Oct-Dec

6.  Excellent response to intralesional bacillus calmette-guérin vaccine in a recalcitrant periungual wart.

Authors:  Piyush Kumar; Anupam Das
Journal:  J Cutan Aesthet Surg       Date:  2014 Oct-Dec

7.  Bacillus Calmette-Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study.

Authors:  Avtar Kishan Jaisinghani; Vivek Kumar Dey; M S Suresh; Animesh Saxena
Journal:  Indian J Dermatol       Date:  2019 Mar-Apr       Impact factor: 1.494

8.  Changes in Cytokine Profile with Immunotherapy in Viral Warts using Purified Protein Derivative, Mumps Measles Rubella Vaccine, and Mycobacterium w Vaccine.

Authors:  Amrita Sil; Sayantan Dasgupta; Somodyuti Chandra; Adrija Datta; Arini Banerjee; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2021 Jan-Feb       Impact factor: 1.494

9.  The management of vulvovaginal warts using intralesional Bacillus Calmette-Guérin immunotherapy.

Authors:  Sunil Kumar Gupta
Journal:  Indian J Sex Transm Dis AIDS       Date:  2020-07-31

10.  Intralesional Injection of the Measles-Mumps-Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial.

Authors:  Mohammad Sadegh Rezai; Hiva Ghasempouri; Ozra Asqary Marzidareh; Jamshid Yazdani Cherati; Ghasem Rahmatpour Rokni
Journal:  Iran J Med Sci       Date:  2019-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.